Skip to main content
. 2022 Jul 6;29(11):1751–1760. doi: 10.1038/s41417-022-00491-0

Fig. 4. Synergistic effect of the MTOR inhibitor torin-1 and the AKT inhibitor capivasertib.

Fig. 4

A Heatmap representation of Bliss interaction index for RCH-ACV cells treated with the MTOR inhibitor torin-1 and the AKT inhibitor capivasertib. Data represent the mean of three independent experiments. B Titration curve for RCH-ACV cells treated with torin-1 in combination with vehicle or capivasertib. Data represent mean ± SEM of three independent experiments. P values were calculated using non-linear regression analysis and curves were compared with the sum-of-squares F test. ns not significant, **p < 0.01.